Institut Català de l'envelliment
Barcelona, 08041, Spain
NCT Number: NCT00479843
The main objective of this study is the improvement of the quality of life and state of health of elderly people with cognitive deterioration and their families through a weight loss prevention programme.
The secondary objectives are the improvement of the state of nutrition, a reduction in the use of resources and a reduction in the burden on the main carer.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Barcelona, 08041, Spain
Main objective The main objective of this project is the evaluation of the effectiveness of a nutrition programme in patients with Alzheimer's or other dementias. Through the Nutrition Programme the idea is to reduce functional and weight loss in elderly people with cognitive deterioration and their families.
Evaluation of the effectiveness of the intervention
-The main evaluation criteria which will allow the effectiveness of this intervention to be evaluated are the reduction in the loss of autonomy measured by the DA/IDA scale.
Secondary objectives
The secondary objectives of this study are:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline, 6 months, 12 months
Time frame: Baseline, 6 months, 12 months
Société des Produits Nestlé (SPN)
Industry
Development of a Programme to Show the Positive Effect of a Nutritional Programme on Preventing Functional and Weight Losses in Patients With Dementia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01505504
Alzheimer Disease, Alzheimer's Disease
Brussels, Belgium
View Trial DetailsNCT00149175
Alzheimer Disease, Alzheimer's Disease
Caen, France
View Trial DetailsNCT04426539
Alzheimer Disease, Alzheimer's Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04603482
Alzheimer Disease, Alzheimer's Disease
Cleveland, Ohio, United States
View Trial Details